Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
||||||||
GSM5814958 |
Neuro2a cells treated with CRISPRa_Rep2
|
SRA | 1 | Nadav Ahituv | Apr 01, 2022 | ||||
GSM5814959 |
Neuro2a cells treated with CRISPRa_Rep3
|
SRA | 1 | Nadav Ahituv | Apr 01, 2022 | ||||
GSM5814960 |
Neuro2a cells treated with CRISPRa_Rep5
|
SRA | 1 | Nadav Ahituv | Apr 01, 2022 | ||||
GSM5814961 |
Neuro2a cells treated with VP64, no sgRNA control_Rep 2
|
SRA | 1 | Nadav Ahituv | Apr 01, 2022 | ||||
GSM5814962 |
Neuro2a cells treated with VP64, no sgRNA control_Rep 3
|
SRA | 1 | Nadav Ahituv | Apr 01, 2022 | ||||
GSM5814963 |
Neuro2a cells treated with VP64, no sgRNA control_Rep 4
|
SRA | 1 | Nadav Ahituv | Apr 01, 2022 | ||||
GSM5983204 |
Neuro2a cells treated with CRISPRa_Rep1
|
SRA | 1 | Nadav Ahituv | Apr 01, 2022 | ||||
GSM5983205 |
Neuro2a cells treated with VP64, no sgRNA control_Rep 5
|
SRA | 1 | Nadav Ahituv | Apr 01, 2022 |